MSD launches new antibiotic in the UK
November 23, 2015Manufacturing and Production, Research and Development
Merck (MSD) has launched the new intravenous antibiotic Zerbaxa (ceftolozane/tazobactam) in the UK, for the treatment of complicated intra-abdominal infections …
Dr Clive Deverson
November 23, 2015OmniaMed UK appoints new senior management OmniaMed strengthens its senior management team by appointing Dr Clive Deverson as Managing Director …
Take the Pharmafocus reader survey today
November 23, 2015Manufacturing and Production, Research and Development
As a valued reader of Pharmafocus, you regularly receive print copies of our market-leading newspaper and have access to the digital …
Pfizer and Allergan confirm record $160 billion merger
November 23, 2015Manufacturing and Production, Research and Development
Pfizer and Allergan have confirmed a $160 billion merger, unanimously approved by their boards of directors, creating the world’s largest …
FDA approves Takeda’s Ninlaro for multiple myeloma
November 23, 2015Manufacturing and Production, Research and Development Takeda, myeloma
The US Food and Drug Administration (FDA) has approved Takeda’s Ninlaro (ixazomib) for use in combination with lenalidomide and dexamethasone …
Pfizer and Allergan on brink of $150 billion merger
November 23, 2015Sales and Marketing
Pfizer is reported to have secured formal board approval for a deal worth more than $150 billion to merge with …
Novartis bags two EU Cosentyx approvals
November 23, 2015Research and Development, Sales and Marketing
The European Commission (EC) has approved Novartis’ Cosentyx (secukinumab) for the treatment of people living with ankylosing spondylitis (AS) and …
Horizon withdraws $1bn Depomed bid
November 20, 2015Sales and Marketing
Horizon Pharma has withdrawn its $1 billion unsolicited offer for Depomed following a block from a California court based on Horizon’s inappropriate …
European Commission approves Amgen’s cancer drug Kyprolis in combo therapy
November 20, 2015Research and Development, Sales and Marketing
The European Commission (EC) has today granted marketing authorization for Amgen’s Kyprolis (carfilzomib) in combination with lenalidomide and dexamethasone for …
Bioproject’s narcolepsy treatment recommended for European approval
November 20, 2015Research and Development, Sales and Marketing
The European Medicines Agency (EMA) has recommended granting a marketing authorisation for Bioproject’s Wakix (pitolisant) for the treatment of narcolepsy …
Biogen’s Enbrel biosimilar gets positive CHMP opinion
November 20, 2015Research and Development, Sales and Marketing
The Committee for Medicinal Products for Human Use (CHMP) today gave a positive opinion to Benepali- the first biosimilar version …
Turing boss Shkreli joins KaloBios as CEO; takes 70% of shares
November 20, 2015Medical Communications, Research and Development
KaloBios Pharmaceuticals has announced the appointment of Turing CEO Martin Shkreli as its own new CEO and his election as …
Alan Dunton appointed senior vice president at Purdue Pharma
November 20, 2015Manufacturing and Production, Medical Communications, Research and Development
Purdue Pharma LP has announced the appointment of Alan Dunton, MD, to the role of senior vice president of Research …
Lilly and Merck extend immuno-oncology collaboration
November 20, 2015Medical Communications, Research and Development Eli Lilly, Merck
Eli Lilly and Merck have announced the extension of their existing collaboration to evaluate the safety and efficacy of the …
Bayer awaits FDA decision on new contraceptive
November 20, 2015Medical Communications, Research and Development
Bayer has submitted a new drug application (NDA) to the FDA, seeking approval for LCS-16, an investigational hormonal intrauterine device …
PMCPA rules on two Bayer conduct breach allegations
November 20, 2015Medical Communications, Sales and Marketing
The pharma industry regulator in the UK, the PMCPA, has ruled on two alleged breaches of the ABPI code of …
Top five pharma controversies of 2015 (so far)
November 20, 2015Medical Communications, Sales and Marketing AstraZeneca, Martin Shkreli, Philidore, Takeda, Turing Pharmaceutical, Valeant, Warner Chilcott, controversies, fraud, reputation, tax avoidance, turing
5. AstraZeneca forced to deny tax avoidance allegations
New partner drives Simon-Kucher’s Life Sciences growth in the UK
November 19, 2015Medical Communications
The global strategy and marketing consultancy Simon-Kucher & Partners has appointed eleven new partners for 2016, with eight of them …
American Medical Association calls for ban on drug commercials
November 19, 2015Medical Communications, Sales and Marketing
The American Medical Association (AMA) has called for a ban on the promotion of prescription products; action which it believes …
NHS England and NICE announce plans for new Cancer Drugs Fund
November 19, 2015Medical Communications, Research and Development Cancer Drugs Fund, NHS England, NICE
A 12-week consultation on draft proposals for a revamped Cancer Drugs Fund (CDF) has been launched by NHS England and NICE, …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
